<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">nnp</journal-id><journal-title-group><journal-title xml:lang="en">Neurology, Neuropsychiatry, Psychosomatics</journal-title><trans-title-group xml:lang="ru"><trans-title>Неврология, нейропсихиатрия, психосоматика</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-2711</issn><issn pub-type="epub">2310-1342</issn><publisher><publisher-name>"IMA-Press", LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/2074-2711-2022-3-4-11</article-id><article-id custom-type="elpub" pub-id-type="custom">nnp-1817</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LECTURES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЛЕКЦИЯ</subject></subj-group></article-categories><title-group><article-title>Acute and long-term neurological disorders in patients with coronavirus infection</article-title><trans-title-group xml:lang="ru"><trans-title>Острые и отдаленные неврологические нарушения у пациентов, перенесших коронавирусную инфекцию</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1992-7960</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Парфенов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Parfenov</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра нервных болезней и нейрохирургии Института клинической медицины им. Н. В. Склифосовского</p><p>119021, Москва, ул. Россолимо, 11, стр. 1</p></bio><bio xml:lang="en"><p>Department of Nervous Diseases and Neurosurgery, N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov</p><p>111, Rossolimo St., Build. 1, Moscow 119021</p></bio><email xlink:type="simple">vladimirparfenov@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6061-8118</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кулеш</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kulesh</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>614990, Пермь, ул. Петропавловская, 26</p></bio><bio xml:lang="en"><p>26, Petropavlovskaya St., Perm 614990</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО «Первый Московский государственный медицинский университет им. И. М. Сеченова» Минздрава России (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Пермский государственный медицинский университет им. акад. Е. А. Вагнера» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Acad. E.A. Vagner Perm State Medical University, Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>19</day><month>06</month><year>2022</year></pub-date><volume>14</volume><issue>3</issue><fpage>4</fpage><lpage>11</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Parfenov V.A., Kulesh A.A., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Парфенов В.А., Кулеш А.А.</copyright-holder><copyright-holder xml:lang="en">Parfenov V.A., Kulesh A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://nnp.ima-press.net/nnp/article/view/1817">https://nnp.ima-press.net/nnp/article/view/1817</self-uri><abstract><p>Currently, patients who attribute their complaints and disorders to the past COVID-19 are turning to a neurologist for a consultation. One should consider dangerous complications of COVID-19 such as stroke, including cerebral venous thrombosis, autoimmune encephalitis and myelitis, posterior reversible encephalopathy syndrome, Guillain–Barre’ syndrome. Disorders of consciousness, disorders of smell and taste, headache and dizziness are significantly more often present in the acute period of COVID-19. Long-term persistence of complaints and disorders after COVID-19 is regarded as post-COVID syndrome (PCS). Neurological complaints and disorders in a patient who has had COVID-19 are often caused by the development or exacerbation of a comorbid disease, including primary headache, musculoskeletal pain in the neck and back, various vestibular disorders, Alzheimer's disease, anxiety and depressive disorders. Unfortunately, in real clinical practice, these diseases are often not diagnosed, patients are observed with a diagnosis of PCS, and it is not taken into account that the basis for diagnosing PCS is the exclusion of other diseases that can explain complaints and disorders in a patient who has suffered from COVID-19.</p></abstract><trans-abstract xml:lang="ru"><p>В настоящее время за консультацией к неврологу обращаются пациенты, которые связывают свои жалобы и расстройства с перенесенным COVID-19. Следует учитывать опасные осложнения COVID-19, такие как инсульт, включая церебральный венозный тромбоз, аутоиммунный энцефалит и миелит, синдром задней обратимой энцефалопатии, синдром Гийена–Барре. Значительно чаще в остром периоде COVID-19 встречаются расстройства сознания, нарушения обоняния и вкуса, головная боль и головокружение. Длительное сохранение жалоб и расстройств после перенесенного COVID-19 расценивается как постковидный синдром (ПКС). Неврологические жалобы и нарушения у пациента, перенесшего COVID-19, часто вызваны развитием или обострением сочетанного заболевания, включая первичную головную боль, скелетно-мышечную боль в шее и спине, различные вестибулярные нарушения, болезнь Альцгеймера, тревожные и депрессивные расстройства. К сожалению, в реальной клинической практике эти заболевания часто не диагностируются, пациенты наблюдаются с диагнозом ПКС, при этом не учитывается, что основа диагностики ПКС – исключение других заболеваний, которыми можно объяснить жалобы и расстройства у пациента, перенесшего COVID-19.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>COVID-19</kwd><kwd>постковидный синдром</kwd><kwd>неврологические осложнения COVID-19</kwd></kwd-group><kwd-group xml:lang="en"><kwd>COVID-19</kwd><kwd>post-COVID syndrome</kwd><kwd>neurological complications of COVID-19</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Stefanou MI, Palaiodimou L, Bakola E, et al. Neurological manifestations of long- COVID syndrome: a narrative review. Ther Adv Chronic Dis. 2022 Feb 17;13:20406223221076890. doi: 10.1177/20406223221076890</mixed-citation><mixed-citation xml:lang="en">Stefanou MI, Palaiodimou L, Bakola E, et al. Neurological manifestations of long- COVID syndrome: a narrative review. Ther Adv Chronic Dis. 2022 Feb 17;13:20406223221076890. doi: 10.1177/20406223221076890</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Долгополов ИС, Менткевич ГЛ, Рыков МЮ, Чичановская ЛВ. Неврологические нарушения у пациентов с long COVID синдромом и методы клеточной терапии для их коррекции: обзор литературы. Сеченовский вестник. 2021;12(3):56-67. doi: 10.47093/2218-7332.2021.12.3.56-67</mixed-citation><mixed-citation xml:lang="en">Dolgopolov IS, Mentkevich GL, Rykov MYu, Chichanovskaya LV. Neurological disorders in patients with long COVID syndrome and cell therapy methods for their correction: a literature review. Sechenovskiy vestnik = Sechenov Medical Journal. 2021;12(3):56-67. doi: 10.47093/2218-7332.2021.12.3.56-67 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Белопасов ВВ, Яшу Я, Самойлова ЕМ, Баклаушев ВП. Поражение нервной системы при СOVID-19. Клиническая практика. 2020;11(2):60-80. doi: 10.17816/clinpract34851</mixed-citation><mixed-citation xml:lang="en">Belopasov VV, Yashu Y, Samoylova EM, Baklaushev VP. The nervous system damage in COVID-19. Klinicheskaya praktika. 2020;11(2):60-80. doi: 10.17816/clinpract34851 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Родионова ОВ, Сорокоумов ВА. Неврологические заболевания в условиях пандемии COVID-19 (обзор литературы). Ученые записки Санкт-Петербургского государственного медицинского университета имени академика И.П. Павлова. 2020;27(2):18-24. doi: 10.24884/1607-4181-2020-27-2-18-24</mixed-citation><mixed-citation xml:lang="en">Rodionova OV, Sorokoumov VA. Neurological diseases in the context of the COVID-19 pandemic (review of the literature). Uchenyye zapiski Sankt-Peterburgskogo gosudarstvennogo meditsinskogo universiteta imeni akademika I.P. Pavlova = The Scientific Notes of the Pavlov University. 2020;27(2):18-24. doi: 10.24884/1607-4181-2020-27-2-18-24 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Холин АА, Заваденко НН, Нестеровский ЮЕ и др. Особенности неврологических проявлений COVID-19 у детей и взрослых. Журнал неврологии и психиатрии им. С.С. Корсакова. 2020;120(9):114-20. doi: 10.17116/jnevro2020120091114</mixed-citation><mixed-citation xml:lang="en">Kholin AA, Zavadenko NN, Nesterovskiy YuE, et al. Features of neurological manifestations of the COVID-19 in children and adults. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2020;120(9):114-20. doi: 10.17116/jnevro2020120091114 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Никитина АЮ, Чимагомедова АШ, Левин ОС. Неврологические проявления COVID-19 у пожилых. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2021;121(10-2):5-15. doi: 10.17116/jnevro20211211025</mixed-citation><mixed-citation xml:lang="en">Nikitina AJ, Chimagomedova ASh, Levin OS. Neurological complications of COVID-19 in elderly people. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2021;121(10-2):5-15. doi: 10.17116/jnevro20211211025 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol. 2017 Aug;264(8):1608-16. doi: 10.1007/s00415-016-8377-8</mixed-citation><mixed-citation xml:lang="en">Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol. 2017 Aug;264(8):1608-16. doi: 10.1007/s00415-016-8377-8</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Iodice F, Cassano V, Rossini PM. Direct and indirect neurological, cognitive, and behavioral effects of COVID-19 on the healthy elderly, mild-cognitive-impairment, and Alzheimer's disease populations. Neurol Sci. 2021 Feb;42(2):455-65. doi: 10.1007/s10072-020-04902-8</mixed-citation><mixed-citation xml:lang="en">Iodice F, Cassano V, Rossini PM. Direct and indirect neurological, cognitive, and behavioral effects of COVID-19 on the healthy elderly, mild-cognitive-impairment, and Alzheimer's disease populations. Neurol Sci. 2021 Feb;42(2):455-65. doi: 10.1007/s10072-020-04902-8</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Cheng Q, Yang Y, Gao J. Infectivity of human coronavirus in the brain. EBioMedicine. 2020 Jun;56:102799. doi: 10.1016/j.ebiom.2020.102799</mixed-citation><mixed-citation xml:lang="en">Cheng Q, Yang Y, Gao J. Infectivity of human coronavirus in the brain. EBioMedicine. 2020 Jun;56:102799. doi: 10.1016/j.ebiom.2020.102799</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Politi LS, Salsano E, Grimaldi M. Magnetic Resonance Imaging Alteration of the Brain in a Patient with Coronavirus Disease 2019 (COVID-19) and Anosmia. JAMA Neurol. 2020 Aug 1;77(8):1028-9. doi: 10.1001/jamaneurol.2020.2125</mixed-citation><mixed-citation xml:lang="en">Politi LS, Salsano E, Grimaldi M. Magnetic Resonance Imaging Alteration of the Brain in a Patient with Coronavirus Disease 2019 (COVID-19) and Anosmia. JAMA Neurol. 2020 Aug 1;77(8):1028-9. doi: 10.1001/jamaneurol.2020.2125</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Aragao MFVV, Leal MC, Cartaxo Filho OQ, et al. Anosmia in COVID-19 Associated with Injury to the Olfactory Bulbs Evident on MRI. AJNR Am J Neuroradiol. 2020 Sep;41(9):1703-6. doi: 10.3174/ajnr.A6675</mixed-citation><mixed-citation xml:lang="en">Aragao MFVV, Leal MC, Cartaxo Filho OQ, et al. Anosmia in COVID-19 Associated with Injury to the Olfactory Bulbs Evident on MRI. AJNR Am J Neuroradiol. 2020 Sep;41(9):1703-6. doi: 10.3174/ajnr.A6675</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Chiu A, Fischbein N, Wintermark M, et al. COVID-19-induced anosmia associated with olfactory bulb atrophy. Neuroradiology. 2021 Jan;63(1):147-8. doi: 10.1007/s00234-020-02554-1. Epub 2020 Sep 15.</mixed-citation><mixed-citation xml:lang="en">Chiu A, Fischbein N, Wintermark M, et al. COVID-19-induced anosmia associated with olfactory bulb atrophy. Neuroradiology. 2021 Jan;63(1):147-8. doi: 10.1007/s00234-020-02554-1. Epub 2020 Sep 15.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Schweitzer F, Goereci Y, Franke C, et al. Cerebrospinal Fluid Analysis Post-COVID-19 Is Not Suggestive of Persistent Central Nervous System Infection. Ann Neurol. 2022 Jan;91(1):150-7. doi: 10.1002/ana.26262. Epub 2021 Nov 22.</mixed-citation><mixed-citation xml:lang="en">Schweitzer F, Goereci Y, Franke C, et al. Cerebrospinal Fluid Analysis Post-COVID-19 Is Not Suggestive of Persistent Central Nervous System Infection. Ann Neurol. 2022 Jan;91(1):150-7. doi: 10.1002/ana.26262. Epub 2021 Nov 22.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol. 2020 Sep;19(9):767-83. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.</mixed-citation><mixed-citation xml:lang="en">Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol. 2020 Sep;19(9):767-83. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Cui Y, Zhao B, Li T, et al. Risk of ischemic stroke in patients with COVID-19 infection: A systematic review and meta-analysis. Brain Res Bull. 2022 Mar;180:31-7. doi: 10.1016/j.brainresbull.2021.12.011. Epub 2021 Dec 31.</mixed-citation><mixed-citation xml:lang="en">Cui Y, Zhao B, Li T, et al. Risk of ischemic stroke in patients with COVID-19 infection: A systematic review and meta-analysis. Brain Res Bull. 2022 Mar;180:31-7. doi: 10.1016/j.brainresbull.2021.12.011. Epub 2021 Dec 31.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Luo W, Liu X, Bao K, Huang C. Ischemic stroke associated with COVID-19: a systematic review and meta-analysis. J Neurol. 2022 Apr;269(4):1731-40. doi: 10.1007/s00415-021-10837-7. Epub 2021 Oct 15.</mixed-citation><mixed-citation xml:lang="en">Luo W, Liu X, Bao K, Huang C. Ischemic stroke associated with COVID-19: a systematic review and meta-analysis. J Neurol. 2022 Apr;269(4):1731-40. doi: 10.1007/s00415-021-10837-7. Epub 2021 Oct 15.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Tan YK, Goh C, Leow AST, et al. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. J Thromb Thrombolysis. 2020 Oct;50(3):587-95. doi: 10.1007/s11239-020-02228-y</mixed-citation><mixed-citation xml:lang="en">Tan YK, Goh C, Leow AST, et al. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. J Thromb Thrombolysis. 2020 Oct;50(3):587-95. doi: 10.1007/s11239-020-02228-y</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Ntaios G, Michel P, Georgiopoulos G, et al. Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke: The Global COVID-19 Stroke Registry. Stroke. 2020 Sep;51(9):e254-e258. doi: 10.1161/STROKEAHA.120.031208. Epub 2020 Jul 9.</mixed-citation><mixed-citation xml:lang="en">Ntaios G, Michel P, Georgiopoulos G, et al. Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke: The Global COVID-19 Stroke Registry. Stroke. 2020 Sep;51(9):e254-e258. doi: 10.1161/STROKEAHA.120.031208. Epub 2020 Jul 9.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Spence JD, de Freitas GR, Pettigrew LC, et al. Mechanisms of Stroke in COVID-19. Cerebrovasc Dis. 2020;49(4):451-8. doi: 10.1159/000509581. Epub 2020 Jul 20.</mixed-citation><mixed-citation xml:lang="en">Spence JD, de Freitas GR, Pettigrew LC, et al. Mechanisms of Stroke in COVID-19. Cerebrovasc Dis. 2020;49(4):451-8. doi: 10.1159/000509581. Epub 2020 Jul 20.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Hess DC, Eldahshan W, Rutkowski E. COVID-19-Related Stroke. Transl Stroke Res. 2020 Jun;11(3):322-5. doi: 10.1007/s12975-020-00818-9. Epub 2020 May 7.</mixed-citation><mixed-citation xml:lang="en">Hess DC, Eldahshan W, Rutkowski E. COVID-19-Related Stroke. Transl Stroke Res. 2020 Jun;11(3):322-5. doi: 10.1007/s12975-020-00818-9. Epub 2020 May 7.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Tsivgoulis G, Palaiodimou L, Zand R, et al. COVID-19 and cerebrovascular diseases: a comprehensive overview. Ther Adv Neurol Disord. 2020 Dec 8;13:1756286420978004. doi: 10.1177/1756286420978004. eCollection 2020.</mixed-citation><mixed-citation xml:lang="en">Tsivgoulis G, Palaiodimou L, Zand R, et al. COVID-19 and cerebrovascular diseases: a comprehensive overview. Ther Adv Neurol Disord. 2020 Dec 8;13:1756286420978004. doi: 10.1177/1756286420978004. eCollection 2020.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Baldini T, Asioli GM, Romoli M, et al. Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infection: A systematic review and meta-analysis. Eur J Neurol. 2021 Oct;28(10):3478-90. doi: 10.1111/ene.14727. Epub 2021 Feb 2.</mixed-citation><mixed-citation xml:lang="en">Baldini T, Asioli GM, Romoli M, et al. Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infection: A systematic review and meta-analysis. Eur J Neurol. 2021 Oct;28(10):3478-90. doi: 10.1111/ene.14727. Epub 2021 Feb 2.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Payus AO, Jeffree MS, Ohn MH, et al. Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-19. Neurol Sci. 2022 Mar;43(3):1533-47. doi: 10.1007/s10072-021-05785-z. Epub 2021 Dec 1.</mixed-citation><mixed-citation xml:lang="en">Payus AO, Jeffree MS, Ohn MH, et al. Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-19. Neurol Sci. 2022 Mar;43(3):1533-47. doi: 10.1007/s10072-021-05785-z. Epub 2021 Dec 1.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Esmaeili S, Abbasi MH, Joghataei MT, et al. Acute disseminated encephalitis (ADEM) as the first presentation of COVID-19; a case report. Ann Med Surg (Lond). 2022 Mar28;77:103511. doi: 10.1016/j.amsu.2022.103511. eCollection 2022 May.</mixed-citation><mixed-citation xml:lang="en">Esmaeili S, Abbasi MH, Joghataei MT, et al. Acute disseminated encephalitis (ADEM) as the first presentation of COVID-19; a case report. Ann Med Surg (Lond). 2022 Mar28;77:103511. doi: 10.1016/j.amsu.2022.103511. eCollection 2022 May.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Gelibter S, Bellavia G, Arbasino C, et al. Encephalopathy as a prognostic factor in adults with acute disseminated encephalomyelitis following COVID-19. J Neurol. 2022 May;269(5):2293-300. doi: 10.1007/s00415-021-10947-2. Epub 2022 Jan 3.</mixed-citation><mixed-citation xml:lang="en">Gelibter S, Bellavia G, Arbasino C, et al. Encephalopathy as a prognostic factor in adults with acute disseminated encephalomyelitis following COVID-19. J Neurol. 2022 May;269(5):2293-300. doi: 10.1007/s00415-021-10947-2. Epub 2022 Jan 3.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Oumerzouk J, Nabil M, Klevor R, et al. Clinicoradiological and prognostic features of COVID-19-associated acute disseminated encephalomyelitis. Rev Neurol (Paris). 2022 Jan-Feb;178(1-2):144-50. doi: 10.1016/j.neurol.2021.11.003. Epub 2021 Nov 27.</mixed-citation><mixed-citation xml:lang="en">Oumerzouk J, Nabil M, Klevor R, et al. Clinicoradiological and prognostic features of COVID-19-associated acute disseminated encephalomyelitis. Rev Neurol (Paris). 2022 Jan-Feb;178(1-2):144-50. doi: 10.1016/j.neurol.2021.11.003. Epub 2021 Nov 27.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Ali L, Mohammed I, Zada Y, et al. COVID-19-Associated Acute Transverse Myelitis: A Case Series of a Rare Neurologic Condition. Cureus. 2021 Oct 6;13(10):e18551. doi: 10.7759/cureus.18551. eCollection 2021 Oct.</mixed-citation><mixed-citation xml:lang="en">Ali L, Mohammed I, Zada Y, et al. COVID-19-Associated Acute Transverse Myelitis: A Case Series of a Rare Neurologic Condition. Cureus. 2021 Oct 6;13(10):e18551. doi: 10.7759/cureus.18551. eCollection 2021 Oct.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Qazi R, Memon A, Mohamed AS, et al. Post-COVID-19 Acute Transverse Myelitis: A Case Report and Literature Review. Cureus. 2021 Dec 22;13(12):e20628. doi: 10.7759/cureus.20628. eCollection 2021 Dec.</mixed-citation><mixed-citation xml:lang="en">Qazi R, Memon A, Mohamed AS, et al. Post-COVID-19 Acute Transverse Myelitis: A Case Report and Literature Review. Cureus. 2021 Dec 22;13(12):e20628. doi: 10.7759/cureus.20628. eCollection 2021 Dec.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Prete S, McShannic JD, Fertel BS, Simon EL. Acute transverse myelitis progressing to permanent quadriplegia following COVID-19 infection. Am J Emerg Med. 2022 Feb 23:S0735-6757(22)00123-1. doi: 10.1016/j.ajem.2022.02.038. Online ahead of print.</mixed-citation><mixed-citation xml:lang="en">Prete S, McShannic JD, Fertel BS, Simon EL. Acute transverse myelitis progressing to permanent quadriplegia following COVID-19 infection. Am J Emerg Med. 2022 Feb 23:S0735-6757(22)00123-1. doi: 10.1016/j.ajem.2022.02.038. Online ahead of print.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Roman GC, Gracia F, Torres A, et al. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222). Front Immunol. 2021 Apr26;12:653786. doi: 10.3389/fimmu.2021.653786. eCollection 2021.</mixed-citation><mixed-citation xml:lang="en">Roman GC, Gracia F, Torres A, et al. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222). Front Immunol. 2021 Apr26;12:653786. doi: 10.3389/fimmu.2021.653786. eCollection 2021.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Iftikhar S, Rehman AU, Ameer MZ, et al. The association of posterior reversible encephalopathy syndrome with COVID-19: A systematic review. Ann Med Surg (Lond). 2021 Dec;72:103080. doi: 10.1016/j.amsu.2021.103080. Epub 2021 Nov 20.</mixed-citation><mixed-citation xml:lang="en">Iftikhar S, Rehman AU, Ameer MZ, et al. The association of posterior reversible encephalopathy syndrome with COVID-19: A systematic review. Ann Med Surg (Lond). 2021 Dec;72:103080. doi: 10.1016/j.amsu.2021.103080. Epub 2021 Nov 20.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Palaiodimou L, Stefanou MI, Katsanos AH, et al. Prevalence, clinical characteristics and outcomes of Guillain-Barrе syndrome spectrum associated with COVID-19: A systematic review and meta-analysis. Eur J Neurol. 2021 Oct;28(10):3517-29. doi: 10.1111/ene.14860. Epub 2021 Apr 28.</mixed-citation><mixed-citation xml:lang="en">Palaiodimou L, Stefanou MI, Katsanos AH, et al. Prevalence, clinical characteristics and outcomes of Guillain-Barrе syndrome spectrum associated with COVID-19: A systematic review and meta-analysis. Eur J Neurol. 2021 Oct;28(10):3517-29. doi: 10.1111/ene.14860. Epub 2021 Apr 28.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Ahmed JO, Ahmad SA, Hassan MN, et al. Post COVID-19 neurological complications; a meta-analysis. Ann Med Surg (Lond). 2022 Apr;76:103440. doi: 10.1016/j.amsu.2022.103440. Epub 2022 Mar 3.</mixed-citation><mixed-citation xml:lang="en">Ahmed JO, Ahmad SA, Hassan MN, et al. Post COVID-19 neurological complications; a meta-analysis. Ann Med Surg (Lond). 2022 Apr;76:103440. doi: 10.1016/j.amsu.2022.103440. Epub 2022 Mar 3.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Bohania N, Ish P, Nune A, Iyengar KP. Cranial neuropathy in COVID-19: a case series and review of literature. Infez Med. 2021 Dec 10;29(4):609-13. doi: 10.53854/liim-2904-15. eCollection 2021.</mixed-citation><mixed-citation xml:lang="en">Bohania N, Ish P, Nune A, Iyengar KP. Cranial neuropathy in COVID-19: a case series and review of literature. Infez Med. 2021 Dec 10;29(4):609-13. doi: 10.53854/liim-2904-15. eCollection 2021.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Tamaki A, Cabrera CI, Li S, et al. Incidence of Bell Palsy in Patients With COVID-19. JAMA Otolaryngol Head Neck Surg. 2021 Aug 1;147(8):767-8. doi: 10.1001/jamaoto.2021.1266</mixed-citation><mixed-citation xml:lang="en">Tamaki A, Cabrera CI, Li S, et al. Incidence of Bell Palsy in Patients With COVID-19. JAMA Otolaryngol Head Neck Surg. 2021 Aug 1;147(8):767-8. doi: 10.1001/jamaoto.2021.1266</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Gupta S, Jawanda MK, Taneja N, Taneja T. A systematic review of Bell's Palsy as the only major neurological manifestation in COVID-19 patients. J Clin Neurosci. 2021 Aug;90:284-92. doi: 10.1016/j.jocn.2021.06.016. Epub 2021 Jun 21.</mixed-citation><mixed-citation xml:lang="en">Gupta S, Jawanda MK, Taneja N, Taneja T. A systematic review of Bell's Palsy as the only major neurological manifestation in COVID-19 patients. J Clin Neurosci. 2021 Aug;90:284-92. doi: 10.1016/j.jocn.2021.06.016. Epub 2021 Jun 21.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Martin-Villares C, Alba JR, Gonzalez-Gimeno MJ. Data from 235 Cases of Bell's Palsy during COVID-19 Pandemic: Were There Clusters of Facial Palsy? Neuroepidemiology. 2021;55(6):495-6. doi: 10.1159/000518671. Epub 2021 Sep 8.</mixed-citation><mixed-citation xml:lang="en">Martin-Villares C, Alba JR, Gonzalez-Gimeno MJ. Data from 235 Cases of Bell's Palsy during COVID-19 Pandemic: Were There Clusters of Facial Palsy? Neuroepidemiology. 2021;55(6):495-6. doi: 10.1159/000518671. Epub 2021 Sep 8.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Halalau A, Halalau M, Carpenter C, et al. Vestibular neuritis caused by severe acute respiratory syndrome coronavirus 2 infection diagnosed by serology: Case report. SAGE Open Med Case Rep. 2021 May 13;9:2050313X211013261. doi: 10.1177/2050313X211013261. eCollection 2021.</mixed-citation><mixed-citation xml:lang="en">Halalau A, Halalau M, Carpenter C, et al. Vestibular neuritis caused by severe acute respiratory syndrome coronavirus 2 infection diagnosed by serology: Case report. SAGE Open Med Case Rep. 2021 May 13;9:2050313X211013261. doi: 10.1177/2050313X211013261. eCollection 2021.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Babu TA, Sarkar MK, Sharmila V. COVID-19 vestibular neuritis (CVN) in a healthcare worker: a rare complication of COVID-19 infection. J R Coll Physicians Edinb. 2021 Jun;51(2):199-207. doi: 10.4997/JRCPE.2021.224</mixed-citation><mixed-citation xml:lang="en">Babu TA, Sarkar MK, Sharmila V. COVID-19 vestibular neuritis (CVN) in a healthcare worker: a rare complication of COVID-19 infection. J R Coll Physicians Edinb. 2021 Jun;51(2):199-207. doi: 10.4997/JRCPE.2021.224</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Kumar S, Veldhuis A, Malhotra T. Neuropsychiatric and Cognitive Sequelae of COVID-19. Front Psychol. 2021 Mar2;12:577529. doi: 10.3389/fpsyg.2021.577529. eCollection 2021.</mixed-citation><mixed-citation xml:lang="en">Kumar S, Veldhuis A, Malhotra T. Neuropsychiatric and Cognitive Sequelae of COVID-19. Front Psychol. 2021 Mar2;12:577529. doi: 10.3389/fpsyg.2021.577529. eCollection 2021.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Yassin A, Nawaiseh M, Shaban A, et al. Neurological manifestations and complications of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. BMC Neurol. 2021 Mar 30;21(1):138. doi: 10.1186/s12883-021-02161-4</mixed-citation><mixed-citation xml:lang="en">Yassin A, Nawaiseh M, Shaban A, et al. Neurological manifestations and complications of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. BMC Neurol. 2021 Mar 30;21(1):138. doi: 10.1186/s12883-021-02161-4</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Stracciari A, Bottini G, Guarino M, et al; “Cognitive and Behavioral Neurology” Study Group of the Italian Neurological Society. Cognitive and behavioral manifestations in SARS-CoV-2 infection: not specific or distinctive features? Neurol Sci. 2021 Jun;42(6):2273-81. doi: 10.1007/s10072-021-05231-0. Epub 2021 Apr 12.</mixed-citation><mixed-citation xml:lang="en">Stracciari A, Bottini G, Guarino M, et al; “Cognitive and Behavioral Neurology” Study Group of the Italian Neurological Society. Cognitive and behavioral manifestations in SARS-CoV-2 infection: not specific or distinctive features? Neurol Sci. 2021 Jun;42(6):2273-81. doi: 10.1007/s10072-021-05231-0. Epub 2021 Apr 12.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Jaywant A, Vanderlind WM, Alexopoulos GS, et al. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology. 2021 Dec;46(13):2235-40. doi: 10.1038/s41386-021-00978-8. Epub 2021 Feb 15.</mixed-citation><mixed-citation xml:lang="en">Jaywant A, Vanderlind WM, Alexopoulos GS, et al. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology. 2021 Dec;46(13):2235-40. doi: 10.1038/s41386-021-00978-8. Epub 2021 Feb 15.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Mazza MG, Palladini M, De Lorenzo R, et al; COVID-19 BioB Outpatient Clinic Study group. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at threemonth follow-up. Brain Behav Immun. 2021 May;94:138-47. doi: 10.1016/j.bbi.2021.02.021. Epub 2021 Feb 24.</mixed-citation><mixed-citation xml:lang="en">Mazza MG, Palladini M, De Lorenzo R, et al; COVID-19 BioB Outpatient Clinic Study group. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at threemonth follow-up. Brain Behav Immun. 2021 May;94:138-47. doi: 10.1016/j.bbi.2021.02.021. Epub 2021 Feb 24.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Mattioli F, Stampatori C, Righetti F, et al. Neurological and cognitive sequelae of COVID-19: a four month follow-up. J Neurol. 2021 Dec;268(12):4422-8. doi: 10.1007/s00415-021-10579-6. Epub 2021 May 1.</mixed-citation><mixed-citation xml:lang="en">Mattioli F, Stampatori C, Righetti F, et al. Neurological and cognitive sequelae of COVID-19: a four month follow-up. J Neurol. 2021 Dec;268(12):4422-8. doi: 10.1007/s00415-021-10579-6. Epub 2021 May 1.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Mattioli F, Piva S, Stampatori C, et al. Neurologic and cognitive sequelae after SARSCoV2 infection: Different impairment for ICU patients. J Neurol Sci. 2022 Jan15;432:120061. doi: 10.1016/j.jns.2021.120061. Epub 2021 Nov 26.</mixed-citation><mixed-citation xml:lang="en">Mattioli F, Piva S, Stampatori C, et al. Neurologic and cognitive sequelae after SARSCoV2 infection: Different impairment for ICU patients. J Neurol Sci. 2022 Jan15;432:120061. doi: 10.1016/j.jns.2021.120061. Epub 2021 Nov 26.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Frontera JA, Yang D, Lewis A, et al. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J Neurol Sci. 2021 Jul15;426:117486. doi: 10.1016/j.jns.2021.117486. Epub 2021 May 12.</mixed-citation><mixed-citation xml:lang="en">Frontera JA, Yang D, Lewis A, et al. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J Neurol Sci. 2021 Jul15;426:117486. doi: 10.1016/j.jns.2021.117486. Epub 2021 May 12.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Hosp JA, Dressing A, Blazhenets G, et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021 May 7;144(4):1263-76. doi: 10.1093/brain/awab009</mixed-citation><mixed-citation xml:lang="en">Hosp JA, Dressing A, Blazhenets G, et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021 May 7;144(4):1263-76. doi: 10.1093/brain/awab009</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Liu YH, Chen Y, Wang QH, et al. One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study. JAMA Neurol. 2022 Mar8:e220461. doi: 10.1001/jamaneurol.2022.0461</mixed-citation><mixed-citation xml:lang="en">Liu YH, Chen Y, Wang QH, et al. One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study. JAMA Neurol. 2022 Mar8:e220461. doi: 10.1001/jamaneurol.2022.0461</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Frontera JA, Yang D, Medicherla C, et al. Trajectories of Neurologic Recovery 12 Months After Hospitalization for COVID-19: A Prospective Longitudinal Study. Neurology. 2022 Mar 21:10.1212/WNL.0000000000200356. doi: 10.1212/WNL.0000000000200356. Online ahead of print.</mixed-citation><mixed-citation xml:lang="en">Frontera JA, Yang D, Medicherla C, et al. Trajectories of Neurologic Recovery 12 Months After Hospitalization for COVID-19: A Prospective Longitudinal Study. Neurology. 2022 Mar 21:10.1212/WNL.0000000000200356. doi: 10.1212/WNL.0000000000200356. Online ahead of print.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Douaud G, Lee S, Alfaro-Almagro F, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022 Apr;604(7907):697-707. doi: 10.1038/s41586-022-04569-5. Epub 2022 Mar 7.</mixed-citation><mixed-citation xml:lang="en">Douaud G, Lee S, Alfaro-Almagro F, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022 Apr;604(7907):697-707. doi: 10.1038/s41586-022-04569-5. Epub 2022 Mar 7.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Voruz P, Cionca A, Jacot de Alcantara I, et al. Functional connectivity underlying cognitive and psychiatric symptoms in post- COVID-19 syndrome: is anosognosia a key determinant? Brain Commun. 2022 Mar 9;4(2):fcac057. doi: 10.1093/braincomms/fcac057</mixed-citation><mixed-citation xml:lang="en">Voruz P, Cionca A, Jacot de Alcantara I, et al. Functional connectivity underlying cognitive and psychiatric symptoms in post- COVID-19 syndrome: is anosognosia a key determinant? Brain Commun. 2022 Mar 9;4(2):fcac057. doi: 10.1093/braincomms/fcac057</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Renaud-Charest O, Lui LMW, Eskander S, et al. Onset and frequency of depression in post-COVID-19 syndrome: A systematic review. J Psychiatr Res. 2021 Dec;144:129-37. doi: 10.1016/j.jpsychires.2021.09.054</mixed-citation><mixed-citation xml:lang="en">Renaud-Charest O, Lui LMW, Eskander S, et al. Onset and frequency of depression in post-COVID-19 syndrome: A systematic review. J Psychiatr Res. 2021 Dec;144:129-37. doi: 10.1016/j.jpsychires.2021.09.054</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Jafari Z, Kolb BE, Mohajerani MH. Hearing Loss, Tinnitus, and Dizziness in COVID-19: A Systematic Review and Meta-Analysis. Can J Neurol Sci. 2022 Mar;49(2):184-95. doi: 10.1017/cjn.2021.63</mixed-citation><mixed-citation xml:lang="en">Jafari Z, Kolb BE, Mohajerani MH. Hearing Loss, Tinnitus, and Dizziness in COVID-19: A Systematic Review and Meta-Analysis. Can J Neurol Sci. 2022 Mar;49(2):184-95. doi: 10.1017/cjn.2021.63</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Gallus R, Melis A, Rizzo D, et al. Audiovestibular symptoms and sequelae in COVID-19 patients. J Vestib Res. 2021;31(5):381-7. doi: 10.3233/VES-201505</mixed-citation><mixed-citation xml:lang="en">Gallus R, Melis A, Rizzo D, et al. Audiovestibular symptoms and sequelae in COVID-19 patients. J Vestib Res. 2021;31(5):381-7. doi: 10.3233/VES-201505</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Almishaal AA, Alrushaidan AA. Shortand Long-Term Self-Reported Audiovestibular Symptoms of SARS-CoV-2 Infection in Hospitalized and Nonhospitalized Patients. Audiol Neurootol. 2022 Mar 3:1-15. doi: 10.1159/000521963. Online ahead of print.</mixed-citation><mixed-citation xml:lang="en">Almishaal AA, Alrushaidan AA. Shortand Long-Term Self-Reported Audiovestibular Symptoms of SARS-CoV-2 Infection in Hospitalized and Nonhospitalized Patients. Audiol Neurootol. 2022 Mar 3:1-15. doi: 10.1159/000521963. Online ahead of print.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Viola P, Ralli M, Pisani D, et al. Tinnitus and equilibrium disorders in COVID-19 patients: preliminary results. Eur Arch Otorhinolaryngol. 2021 Oct;278(10):3725-30. doi: 10.1007/s00405-020-06440-7</mixed-citation><mixed-citation xml:lang="en">Viola P, Ralli M, Pisani D, et al. Tinnitus and equilibrium disorders in COVID-19 patients: preliminary results. Eur Arch Otorhinolaryngol. 2021 Oct;278(10):3725-30. doi: 10.1007/s00405-020-06440-7</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Daher GS, Nassiri AM, Vanichkachorn G, et al. New onset tinnitus in the absence of hearing changes following COVID-19 infection. Am J Otolaryngol. 2022 Jan- Feb;43(1):103208. doi: 10.1016/j.amjoto.2021.103208</mixed-citation><mixed-citation xml:lang="en">Daher GS, Nassiri AM, Vanichkachorn G, et al. New onset tinnitus in the absence of hearing changes following COVID-19 infection. Am J Otolaryngol. 2022 Jan- Feb;43(1):103208. doi: 10.1016/j.amjoto.2021.103208</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Garcia-Azorin D, Layos-Romero A, Porta-Etessam J, et al. Post-COVID-19 persistent headache: A multicentric 9-months followup study of 905 patients. Cephalalgia. 2022 Feb 15:3331024211068074. doi: 10.1177/03331024211068074</mixed-citation><mixed-citation xml:lang="en">Garcia-Azorin D, Layos-Romero A, Porta-Etessam J, et al. Post-COVID-19 persistent headache: A multicentric 9-months followup study of 905 patients. Cephalalgia. 2022 Feb 15:3331024211068074. doi: 10.1177/03331024211068074</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Fernandez-de-Las-Penas C, Navarro-Santana M, Gomez-Mayordomo V, et al. Headache as an acute and post- COVID-19 symptom in COVID-19 survivors: A meta-analysis of the current literature. Eur J Neurol. 2021 Nov;28(11):3820-5. doi: 10.1111/ene.15040</mixed-citation><mixed-citation xml:lang="en">Fernandez-de-Las-Penas C, Navarro-Santana M, Gomez-Mayordomo V, et al. Headache as an acute and post- COVID-19 symptom in COVID-19 survivors: A meta-analysis of the current literature. Eur J Neurol. 2021 Nov;28(11):3820-5. doi: 10.1111/ene.15040</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Wang L, Yang N, Yang J, et al. A Review: The Manifestations, Mechanisms, and Treatments of Musculoskeletal Pain in Patients with COVID-19. Front Pain Res (Lausanne). 2022 Mar10;3:826160. doi: 10.3389/fpain.2022.826160</mixed-citation><mixed-citation xml:lang="en">Wang L, Yang N, Yang J, et al. A Review: The Manifestations, Mechanisms, and Treatments of Musculoskeletal Pain in Patients with COVID-19. Front Pain Res (Lausanne). 2022 Mar10;3:826160. doi: 10.3389/fpain.2022.826160</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020 Feb 19;368:m606. doi: 10.1136/bmj.m606</mixed-citation><mixed-citation xml:lang="en">Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020 Feb 19;368:m606. doi: 10.1136/bmj.m606</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Lippi G, Wong J, Henry BM. Myalgia may not be associated with severity of coronavirus disease 2019 (COVID-19). World J Emerg Med. 2020;11(3):193-4. doi: 10.5847/wjem.j.1920-8642.2020.03.013</mixed-citation><mixed-citation xml:lang="en">Lippi G, Wong J, Henry BM. Myalgia may not be associated with severity of coronavirus disease 2019 (COVID-19). World J Emerg Med. 2020;11(3):193-4. doi: 10.5847/wjem.j.1920-8642.2020.03.013</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Tuzun S, Keles A, Okutan D, et al. Assessment of musculoskeletal pain, fatigue and grip strength in hospitalized patients with COVID-19. Eur J Phys Rehabil Med. 2021 Aug;57(4):653-62. doi: 10.23736/S1973-9087.20.06563-6</mixed-citation><mixed-citation xml:lang="en">Tuzun S, Keles A, Okutan D, et al. Assessment of musculoskeletal pain, fatigue and grip strength in hospitalized patients with COVID-19. Eur J Phys Rehabil Med. 2021 Aug;57(4):653-62. doi: 10.23736/S1973-9087.20.06563-6</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021 Jan 22;372:n136. doi: 10.1136/bmj.n136</mixed-citation><mixed-citation xml:lang="en">Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021 Jan 22;372:n136. doi: 10.1136/bmj.n136</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Fernandez-de-Las-Penas C, Navarro-Santana M, Plaza-Manzano G, et al. Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived to severe acute respiratory syndrome coronavirus 2 infection: a systematic review and meta-analysis. Pain. 2021 Sep 23. doi: 10.1097/j.pain.0000000000002496. Online ahead of print.</mixed-citation><mixed-citation xml:lang="en">Fernandez-de-Las-Penas C, Navarro-Santana M, Plaza-Manzano G, et al. Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived to severe acute respiratory syndrome coronavirus 2 infection: a systematic review and meta-analysis. Pain. 2021 Sep 23. doi: 10.1097/j.pain.0000000000002496. Online ahead of print.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Fernandez-de-Las-Penas C, de-la-Llave-Rincon AI, Ortega-Santiago R, et al. Prevalence and risk factors of musculoskeletal pain symptoms as long-term post- COVID sequelae in hospitalized COVID-19 survivors: a multicenter study. Pain. 2021 Dec 10. doi: 10.1097/j.pain.0000000000002564. Online ahead of print.</mixed-citation><mixed-citation xml:lang="en">Fernandez-de-Las-Penas C, de-la-Llave-Rincon AI, Ortega-Santiago R, et al. Prevalence and risk factors of musculoskeletal pain symptoms as long-term post- COVID sequelae in hospitalized COVID-19 survivors: a multicenter study. Pain. 2021 Dec 10. doi: 10.1097/j.pain.0000000000002564. Online ahead of print.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Suresh K, Alam MDU, Satkovich E. COVID-19-Associated Dysautonomia. Cureus. 2021 Aug 13;13(8):e17156. doi: 10.7759/cureus.17156. eCollection 2021 Aug.</mixed-citation><mixed-citation xml:lang="en">Suresh K, Alam MDU, Satkovich E. COVID-19-Associated Dysautonomia. Cureus. 2021 Aug 13;13(8):e17156. doi: 10.7759/cureus.17156. eCollection 2021 Aug.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Shouman K, Vanichkachorn G, Cheshire WP, et al. Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res. 2021 Jun;31(3):385-94. doi: 10.1007/s10286-021-00803-8. Epub 2021 Apr 16.</mixed-citation><mixed-citation xml:lang="en">Shouman K, Vanichkachorn G, Cheshire WP, et al. Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res. 2021 Jun;31(3):385-94. doi: 10.1007/s10286-021-00803-8. Epub 2021 Apr 16.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Chadda KR, Blakey EE, Huang CL, Jeevaratnam K. Long COVID-19 and Postural Orthostatic Tachycardia Syndrome – Is Dysautonomia to Be Blamed? Front Cardiovasc Med. 2022 Mar9;9:860198. doi: 10.3389/fcvm.2022.860198. eCollection 2022.</mixed-citation><mixed-citation xml:lang="en">Chadda KR, Blakey EE, Huang CL, Jeevaratnam K. Long COVID-19 and Postural Orthostatic Tachycardia Syndrome – Is Dysautonomia to Be Blamed? Front Cardiovasc Med. 2022 Mar9;9:860198. doi: 10.3389/fcvm.2022.860198. eCollection 2022.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Blitshteyn S, Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res. 2021 Apr;69(2):205-11. doi: 10.1007/s12026-021-09185-5</mixed-citation><mixed-citation xml:lang="en">Blitshteyn S, Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res. 2021 Apr;69(2):205-11. doi: 10.1007/s12026-021-09185-5</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence (NICE); 2020 Dec 18.</mixed-citation><mixed-citation xml:lang="en">COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence (NICE); 2020 Dec 18.</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Bliddal S, Banasik K, Pedersen OB, et al. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci Rep. 2021 Jun 23;11(1):13153. doi: 10.1038/s41598-021-92045-x</mixed-citation><mixed-citation xml:lang="en">Bliddal S, Banasik K, Pedersen OB, et al. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci Rep. 2021 Jun 23;11(1):13153. doi: 10.1038/s41598-021-92045-x</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021 Aug;38:101019. doi: 10.1016/j.eclinm.2021.101019. Epub 2021 Jul 15.</mixed-citation><mixed-citation xml:lang="en">Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021 Aug;38:101019. doi: 10.1016/j.eclinm.2021.101019. Epub 2021 Jul 15.</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Anaya JM, Rojas M, Salinas ML, et al. Post-COVID syndrome. A case series and comprehensive review. Autoimmun Rev. 2021 Nov;20(11):102947. doi: 10.1016/j.autrev.2021.102947</mixed-citation><mixed-citation xml:lang="en">Anaya JM, Rojas M, Salinas ML, et al. Post-COVID syndrome. A case series and comprehensive review. Autoimmun Rev. 2021 Nov;20(11):102947. doi: 10.1016/j.autrev.2021.102947</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Rass V, Beer R, Schiefecker AJ, et al. Neurological outcomes 1 year after COVID-19 diagnosis: A prospective longitudinal cohort study. Eur J Neurol. 2022 Jun;29(6):1685-96. doi: 10.1111/ene.15307. Epub 2022 Mar 23.</mixed-citation><mixed-citation xml:lang="en">Rass V, Beer R, Schiefecker AJ, et al. Neurological outcomes 1 year after COVID-19 diagnosis: A prospective longitudinal cohort study. Eur J Neurol. 2022 Jun;29(6):1685-96. doi: 10.1111/ene.15307. Epub 2022 Mar 23.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
